Loading data
CHMINYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 9.28 m USD | 12.42 m USD | 11.25 m USD | 11.84 m USD | 13.62 m USD |
| Interest expense | — | — | 51.64 m USD | 17.56 m USD | 5.77 m USD |
| Profit before tax | 9.14 m USD | 16.31 m USD | -34.93 m USD | 27.26 m USD | 13.31 m USD |
| Income tax expense | 2.2 m USD | 4.1 m USD | 523 k USD | 5.07 m USD | 781 k USD |
| Net income (reported basis) | 6.94 m USD | 12.21 m USD | -35.46 m USD | 22.19 m USD | 12.53 m USD |
| Net income attributable to common shareholders | -3 m USD | 2.05 m USD | -44.65 m USD | 11.89 m USD | 2.43 m USD |
| Basic earnings per share | -0.09 USD/share | 0.07 USD/share | -1.7 USD/share | 0.6 USD/share | 0.14 USD/share |
| Diluted earnings per share | -0.09 USD/share | 0.07 USD/share | -1.7 USD/share | 0.6 USD/share | 0.14 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.